Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00203255 · ClinicalTrials.gov registry record · NA
Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache
A NA study of Migraine Headache, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT00203255 is a NA study of Migraine Headache that has completed, run by Thomas Jefferson University. The registered enrollment target is 25 participants, below the 155-participant average among 6 other Migraine Headache trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00203255, a NA study of Migraine Headache, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this trial is to study the use of soy isoflavones in the prevention of menstrually-associated migraines. Additionally, this trial may provide insight into the menstrual cycle and menstrually-related headaches in women. With this information, we may be able to change current treatment methods or even develop new methods in order to advance current approaches in the treatment of menstrual migraine.
Conditions Studied
Interventions
- DRUG Soy Isoflavones
Study Locations (1)
Pennsylvania
- Jefferson Headache Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2003-05 |
| Est. Completion | 2005-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00203255
The ClinicalTrials.gov registry entry for NCT00203255 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 155-participant average among 6 other Migraine Headache trials with a reported enrollment target (84% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Migraine Headache appearing as the primary indexed condition, and to 1 intervention - of which Soy Isoflavones is the first listed.
NCT00203255 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00203255 about?
NCT00203255 is a clinical study titled "Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache". The purpose of this trial is to study the use of soy isoflavones in the prevention of menstrually-associated migraines. Additionally, this trial may provide insight into the menstrual cycle and menstrually-related headaches in women. With this information, we may be able to change current treatment ...
What is the current status of trial NCT00203255?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2003-05. Estimated completion is 2005-03.
What conditions does trial NCT00203255 study?
This clinical trial studies the following conditions: Migraine Headache.
What interventions are being tested in trial NCT00203255?
The interventions under investigation include: Soy Isoflavones (DRUG).
Who is sponsoring clinical trial NCT00203255?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00203255 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine Headache
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Light Exposure, Migraine Outcomes, and Sleep Quality
RECRUITING · NA
-
TelemEdiciNe-bAsed Cognitive TherapY for Migraines
COMPLETED · NA
-
Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine
COMPLETED · NA
-
Efficacy, Tolerability, and Safety of DFN-15
COMPLETED · Phase 3
-
Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache
COMPLETED · Phase 2
-
Greater Occipital Nerve Block for Migraine Prophylaxis
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.